HONG KONG (Reuters) – Hong Kong said on Friday that children aged 5 to 11 would be able to receive the paediatric formulation of the BioNTech COVID-19 vaccine from Nov. 2, part of broader measures to boost vaccination uptake in the financial hub.
“In the face of the threat posed by the highly transmissible mutant virus strains, children are among our focuses of protection in the COVID-19 Vaccination Programme,” the government spokesman said in a statement.
(Reporting by Twinnie Siu; Editing by Susan Fenton)
